| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 16 | 2024 | 201 | 3.320 |
Why?
|
| DiGeorge Syndrome | 8 | 2023 | 79 | 1.800 |
Why?
|
| Thymus Gland | 8 | 2013 | 100 | 1.740 |
Why?
|
| Genetic Testing | 5 | 2021 | 997 | 1.680 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 5 | 2021 | 145 | 1.110 |
Why?
|
| Killer Cells, Natural | 8 | 2024 | 320 | 1.070 |
Why?
|
| Severe Combined Immunodeficiency | 5 | 2018 | 105 | 0.870 |
Why?
|
| Mutation | 17 | 2025 | 5767 | 0.780 |
Why?
|
| RGS Proteins | 1 | 2021 | 47 | 0.750 |
Why?
|
| Parathyroid Glands | 2 | 2011 | 28 | 0.720 |
Why?
|
| Phenotype | 12 | 2025 | 4226 | 0.700 |
Why?
|
| Body Height | 1 | 2021 | 210 | 0.690 |
Why?
|
| Transplantation Tolerance | 2 | 2010 | 15 | 0.650 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 862 | 0.580 |
Why?
|
| Herpesvirus 4, Human | 3 | 2021 | 670 | 0.540 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 269 | 0.530 |
Why?
|
| Sirolimus | 1 | 2018 | 220 | 0.520 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2016 | 195 | 0.520 |
Why?
|
| Transplantation, Homologous | 5 | 2011 | 659 | 0.520 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 340 | 0.510 |
Why?
|
| Cytomegalovirus Infections | 2 | 2018 | 217 | 0.510 |
Why?
|
| Genomics | 3 | 2022 | 1474 | 0.500 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 65 | 0.490 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 289 | 0.480 |
Why?
|
| Alleles | 8 | 2025 | 1603 | 0.470 |
Why?
|
| Gain of Function Mutation | 4 | 2018 | 105 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2020 | 3080 | 0.460 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 367 | 0.440 |
Why?
|
| Haploinsufficiency | 3 | 2023 | 247 | 0.430 |
Why?
|
| Humans | 65 | 2025 | 123180 | 0.420 |
Why?
|
| B-Lymphocytes | 6 | 2025 | 518 | 0.420 |
Why?
|
| Genome, Human | 2 | 2025 | 1265 | 0.410 |
Why?
|
| Lymphatic System | 1 | 2012 | 20 | 0.400 |
Why?
|
| Infant | 20 | 2025 | 12371 | 0.370 |
Why?
|
| Agammaglobulinemia | 2 | 2021 | 39 | 0.370 |
Why?
|
| STAT1 Transcription Factor | 3 | 2025 | 69 | 0.350 |
Why?
|
| Carrier Proteins | 3 | 2021 | 1017 | 0.340 |
Why?
|
| Actins | 2 | 2024 | 341 | 0.340 |
Why?
|
| Immunophenotyping | 5 | 2018 | 328 | 0.330 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2021 | 224 | 0.320 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2020 | 26 | 0.310 |
Why?
|
| Membrane Proteins | 3 | 2020 | 1522 | 0.290 |
Why?
|
| Genetic Association Studies | 6 | 2021 | 760 | 0.290 |
Why?
|
| Heterozygote | 5 | 2025 | 678 | 0.280 |
Why?
|
| Child, Preschool | 17 | 2025 | 13904 | 0.270 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 250 | 0.270 |
Why?
|
| Male | 32 | 2025 | 60173 | 0.250 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2023 | 1199 | 0.240 |
Why?
|
| Aging | 1 | 2012 | 1176 | 0.240 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 482 | 0.240 |
Why?
|
| Female | 31 | 2025 | 65562 | 0.240 |
Why?
|
| Penetrance | 1 | 2025 | 103 | 0.230 |
Why?
|
| Child | 20 | 2025 | 24247 | 0.230 |
Why?
|
| Hypersensitivity | 2 | 2024 | 182 | 0.230 |
Why?
|
| Dermatitis | 1 | 2024 | 25 | 0.230 |
Why?
|
| Neutropenia | 2 | 2022 | 202 | 0.220 |
Why?
|
| Phospholipase C gamma | 1 | 2023 | 17 | 0.220 |
Why?
|
| Pedigree | 7 | 2021 | 1576 | 0.220 |
Why?
|
| Disease Management | 2 | 2018 | 516 | 0.220 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 22 | 0.210 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 1268 | 0.210 |
Why?
|
| CHARGE Syndrome | 1 | 2023 | 8 | 0.210 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 47 | 0.210 |
Why?
|
| Arthritis | 2 | 2020 | 81 | 0.200 |
Why?
|
| Colitis | 1 | 2024 | 151 | 0.200 |
Why?
|
| Developmental Disabilities | 2 | 2025 | 702 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2025 | 467 | 0.190 |
Why?
|
| DNA-Binding Proteins | 4 | 2025 | 2055 | 0.190 |
Why?
|
| Nonsense Mediated mRNA Decay | 2 | 2018 | 29 | 0.190 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 297 | 0.190 |
Why?
|
| DNA Damage | 3 | 2020 | 512 | 0.190 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 9 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2020 | 849 | 0.180 |
Why?
|
| Adolescent | 13 | 2025 | 19111 | 0.180 |
Why?
|
| Homozygote | 2 | 2020 | 532 | 0.180 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2020 | 9 | 0.180 |
Why?
|
| Lymphopenia | 1 | 2021 | 36 | 0.180 |
Why?
|
| GTP-Binding Proteins | 1 | 2021 | 171 | 0.180 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 18 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 140 | 0.180 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 28 | 0.180 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 940 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 1752 | 0.170 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 153 | 0.170 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2020 | 2 | 0.170 |
Why?
|
| Magnesium Deficiency | 1 | 2020 | 10 | 0.170 |
Why?
|
| Sepsis | 2 | 2021 | 476 | 0.170 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2020 | 6 | 0.170 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 31 | 0.170 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 25 | 0.170 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 151 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 151 | 0.160 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2019 | 11 | 0.160 |
Why?
|
| Infant, Newborn | 6 | 2022 | 8115 | 0.160 |
Why?
|
| Immunologic Memory | 1 | 2020 | 184 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 279 | 0.160 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1909 | 0.160 |
Why?
|
| Cell Line | 5 | 2024 | 2771 | 0.160 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.160 |
Why?
|
| Lymphopoiesis | 2 | 2021 | 10 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 281 | 0.160 |
Why?
|
| Guanylate Cyclase | 1 | 2018 | 37 | 0.150 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 34 | 0.150 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2018 | 43 | 0.150 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 68 | 0.150 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 67 | 0.150 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 72 | 0.150 |
Why?
|
| Immune System Diseases | 1 | 2018 | 43 | 0.150 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 1876 | 0.150 |
Why?
|
| Alemtuzumab | 1 | 2018 | 88 | 0.150 |
Why?
|
| Immunological Synapses | 1 | 2018 | 26 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 548 | 0.150 |
Why?
|
| Chromatin | 1 | 2021 | 554 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 228 | 0.140 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 74 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 167 | 0.140 |
Why?
|
| Viremia | 1 | 2018 | 126 | 0.140 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 136 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 489 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2021 | 809 | 0.140 |
Why?
|
| Models, Immunological | 2 | 2020 | 35 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 555 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 263 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 38 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2014 | 60 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2019 | 457 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 348 | 0.130 |
Why?
|
| Lymphoma | 1 | 2019 | 324 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2016 | 169 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 492 | 0.130 |
Why?
|
| Coatomer Protein | 1 | 2016 | 31 | 0.130 |
Why?
|
| Chromosome Breakage | 1 | 2016 | 168 | 0.130 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2016 | 141 | 0.130 |
Why?
|
| Lung Diseases | 2 | 2016 | 378 | 0.130 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 684 | 0.130 |
Why?
|
| Computational Biology | 1 | 2020 | 804 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2019 | 3040 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 472 | 0.120 |
Why?
|
| Codon, Nonsense | 3 | 2021 | 131 | 0.120 |
Why?
|
| Animals | 10 | 2023 | 33798 | 0.120 |
Why?
|
| Young Adult | 8 | 2025 | 8864 | 0.120 |
Why?
|
| Genetic Variation | 2 | 2019 | 1479 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2017 | 304 | 0.120 |
Why?
|
| HEK293 Cells | 3 | 2025 | 741 | 0.120 |
Why?
|
| Virus Diseases | 2 | 2016 | 279 | 0.120 |
Why?
|
| Autophagy | 1 | 2018 | 390 | 0.120 |
Why?
|
| Janus Kinase 1 | 2 | 2025 | 14 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2022 | 2587 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2018 | 363 | 0.120 |
Why?
|
| Cytokines | 1 | 2020 | 1284 | 0.120 |
Why?
|
| Syndrome | 4 | 2021 | 1115 | 0.110 |
Why?
|
| Adult | 10 | 2021 | 29032 | 0.110 |
Why?
|
| Chromosome Deletion | 2 | 2023 | 639 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1047 | 0.110 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 1804 | 0.110 |
Why?
|
| Neonatal Screening | 1 | 2015 | 184 | 0.110 |
Why?
|
| Epilepsy | 1 | 2021 | 858 | 0.110 |
Why?
|
| Parents | 2 | 2011 | 1033 | 0.110 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2013 | 14 | 0.110 |
Why?
|
| Clone Cells | 1 | 2013 | 163 | 0.110 |
Why?
|
| Inflammation | 4 | 2024 | 1403 | 0.100 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 393 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2023 | 4494 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2021 | 4703 | 0.100 |
Why?
|
| Abnormalities, Multiple | 2 | 2016 | 962 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2013 | 331 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 95 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 643 | 0.100 |
Why?
|
| Asthma | 1 | 2019 | 744 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2024 | 172 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2021 | 3327 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2013 | 340 | 0.090 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 33 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 216 | 0.090 |
Why?
|
| Mice | 7 | 2023 | 17542 | 0.090 |
Why?
|
| Family | 3 | 2020 | 571 | 0.090 |
Why?
|
| Pseudolymphoma | 1 | 2010 | 4 | 0.090 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2010 | 39 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 1638 | 0.090 |
Why?
|
| Risk Factors | 3 | 2021 | 10031 | 0.090 |
Why?
|
| BRCA2 Protein | 1 | 2010 | 43 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 79 | 0.090 |
Why?
|
| T-Lymphocytes | 4 | 2025 | 1697 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2010 | 103 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2012 | 324 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2011 | 145 | 0.090 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 148 | 0.090 |
Why?
|
| Binding Sites | 2 | 2025 | 1292 | 0.080 |
Why?
|
| Prognosis | 1 | 2018 | 4512 | 0.080 |
Why?
|
| Chromosomes | 2 | 2023 | 199 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2012 | 372 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 464 | 0.080 |
Why?
|
| Protein Binding | 2 | 2025 | 1741 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2022 | 213 | 0.080 |
Why?
|
| Graft Survival | 1 | 2010 | 530 | 0.070 |
Why?
|
| DNA Replication | 2 | 2022 | 350 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2524 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2021 | 3235 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 795 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2019 | 3722 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2007 | 496 | 0.060 |
Why?
|
| Neoplasms | 1 | 2019 | 2756 | 0.060 |
Why?
|
| Zinc Fingers | 1 | 2025 | 119 | 0.060 |
Why?
|
| United States | 1 | 2019 | 10660 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12142 | 0.060 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 8 | 0.050 |
Why?
|
| Busulfan | 1 | 2023 | 44 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2019 | 880 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 25 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 2023 | 142 | 0.050 |
Why?
|
| Exome | 2 | 2018 | 1040 | 0.050 |
Why?
|
| Genotype | 2 | 2019 | 2533 | 0.050 |
Why?
|
| Liver | 1 | 2009 | 1736 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2056 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 13 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2024 | 333 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2307 | 0.050 |
Why?
|
| Cell Division | 1 | 2022 | 780 | 0.050 |
Why?
|
| Histones | 1 | 2025 | 527 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 422 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2025 | 448 | 0.050 |
Why?
|
| Consanguinity | 1 | 2021 | 104 | 0.040 |
Why?
|
| Joints | 1 | 2020 | 23 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 7 | 0.040 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2020 | 7 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 2020 | 31 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 54 | 0.040 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 49 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 180 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2021 | 117 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2025 | 2695 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 314 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 1 | 2020 | 13 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 171 | 0.040 |
Why?
|
| India | 1 | 2020 | 217 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 142 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 114 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 236 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 280 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 355 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 100 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 350 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 2943 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 217 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 96 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 499 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 558 | 0.040 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2018 | 5 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 190 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2018 | 9 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 222 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2021 | 403 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 989 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 28 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 470 | 0.040 |
Why?
|
| Ferritins | 1 | 2018 | 96 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 280 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 28 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 40 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 317 | 0.040 |
Why?
|
| Time Factors | 2 | 2007 | 6221 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 198 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2018 | 82 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 792 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 112 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 420 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2018 | 107 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2017 | 31 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 238 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 240 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 281 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 175 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 120 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 140 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2016 | 26 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 533 | 0.030 |
Why?
|
| Nitriles | 1 | 2017 | 145 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 261 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 126 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1237 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 645 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 81 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 790 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1610 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 996 | 0.030 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2016 | 15 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 62 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2016 | 69 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 386 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 463 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 58 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 701 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 115 | 0.030 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2016 | 21 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 1070 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 874 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 470 | 0.030 |
Why?
|
| Mitosis | 1 | 2016 | 238 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 769 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 794 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 259 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2016 | 447 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 375 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2014 | 13 | 0.030 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2014 | 11 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 711 | 0.030 |
Why?
|
| Complementarity Determining Regions | 1 | 2014 | 25 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 3091 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2023 | 6029 | 0.030 |
Why?
|
| DNA Repair | 1 | 2016 | 579 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 622 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3291 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 2028 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 3565 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 478 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2809 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 544 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3045 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4288 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 231 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1258 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5040 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2010 | 376 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 19108 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 2008 | 65 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 803 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 505 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2008 | 243 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 26015 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 246 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1006 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2018 | 16062 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2007 | 1473 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 1236 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1980 | 630 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 1980 | 23 | 0.000 |
Why?
|
| Herpes Simplex | 1 | 1980 | 56 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1980 | 587 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1980 | 1139 | 0.000 |
Why?
|